Personalised medicine to treat ADHD

Objectification as part of the ADHD medicine

Today the diagnosis and the therapy in the treatment of ADHD are heavily influenced by subjective factors.

By sponsoring a research project by the Gehirn- und Traumastiftung Graubünden (Grisons Brain and Trauma Foundation), the Hirschmann Foundation intends to contribute to the objectification of the diagnosis and therapy in the ADHD medicine.

Testing of new measuring procedures

The aim is to reduce the current risk of medication and non-medication failures by testing new measurement procedures that use biomarkers.

The focus is to determine the best possible way to support people who suffer from ADHD.

The research concept developed by the Gehirn- und Traumastiftung (Brain and Trauma Foundation) will be implemented in cooperation with the Psychiatric University Clinic of Zürich (Psychiatric University Hospital Zurich) and practising doctors and therapists as well as with computer scientists.

Illuminating interrelationships

The biomarker data collected will be correlated with different therapy and treatment strategies, and the correlations postulated will be tested for their actual effectiveness.

Once the research work has been completed, the findings obtained will be made available to anyone with an interest in this area as a scientific publication.

Partners

The partners of the Hirschmann Foundation are the Brain and Trauma Foundation Chur (Dr. Giusep Nay and Dr. Andreas Müller), the Clinic for Psychiatry, Psychotherapy and Psychosomatics at the Psychiatric University Clinic Zurich (Prof. Dr. med. Erich Seifritz, Director of the Clinic for Psychiatry, Psychotherapy and Psychosomatics and Prof. Dr. med. Dominique Eich-Höchli, Head Physician of the Psychiatric University Clinic) and Prof. Juri Kropotov, Director of laboratory of the Institute of the Human Brain of the Russian Academy of Sciences, St. Petersburg.